Nexocin Ec (Naproxen)

Naproxen works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, naproxen reduces inflammation, pain signaling, and fever at the site of tissue injury.

The appropriate dose of naproxen is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Naproxen is generally avoided during the third trimester of pregnancy because of potential risks to the fetus and labor complications. Use during earlier trimesters should be discussed with a healthcare provider. While limited data exist for breastfeeding, caution is advised and a clinician should evaluate the risk‑benefit ratio.

To order Nexocin Ec, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Naproxen and ibuprofen are both NSAIDs with similar mechanisms, but naproxen has a longer half‑life, allowing less frequent dosing. Ibuprofen may have a slightly lower gastrointestinal risk at short‑term use, whereas naproxen is often preferred for chronic conditions due to its sustained effect. Individual response and safety profile guide selection.

Nexocin Ec should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, excessive heat and direct sunlight. Do not store in a refrigerator or freezer, and keep out of reach of children.

Nexocin Ec is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. The tablet should be swallowed whole and not chewed or crushed unless specifically directed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, and severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice black stools, sudden chest pain, shortness of breath, or widespread rash.

Naproxen is contraindicated in individuals with known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe heart failure, and patients in the third trimester of pregnancy. Caution is also advised for patients with impaired renal or hepatic function.